Elutia Inc. (ELUT) - Total Assets
Based on the latest financial reports, Elutia Inc. (ELUT) holds total assets worth $29.41 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Elutia Inc. shareholders equity for net asset value and shareholders' equity analysis.
Elutia Inc. - Total Assets Trend (2018–2024)
This chart illustrates how Elutia Inc.'s total assets have evolved over time, based on quarterly financial data.
Elutia Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Elutia Inc.'s total assets of $29.41 Million consist of 72.4% current assets and 27.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 36.7% |
| Accounts Receivable | $7.04 Million | 19.5% |
| Inventory | $3.91 Million | 10.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $8.27 Million | 22.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Elutia Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ELUT market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elutia Inc.'s current assets represent 72.4% of total assets in 2024, an increase from 38.0% in 2018.
- Cash Position: Cash and equivalents constituted 36.7% of total assets in 2024, up from 5.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 22.9% of total assets.
Elutia Inc. Competitors by Total Assets
Key competitors of Elutia Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Elutia Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.44 | 0.94 | 1.74 |
| Quick Ratio | 0.40 | 0.85 | 1.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-22.96 Million | $-2.36 Million | $16.74 Million |
Elutia Inc. - Advanced Valuation Insights
This section examines the relationship between Elutia Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 1.13 |
| Asset Growth Rate (YoY) | -16.8% |
| Total Assets | $36.13 Million |
| Market Capitalization | $40.75 Million USD |
Valuation Analysis
Above Book Valuation: The market values Elutia Inc.'s assets above their book value (1.13x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Elutia Inc.'s assets decreased by 16.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Elutia Inc. (2018–2024)
The table below shows the annual total assets of Elutia Inc. from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $36.13 Million | -16.81% |
| 2023-12-31 | $43.43 Million | -36.92% |
| 2022-12-31 | $68.84 Million | +2.49% |
| 2021-12-31 | $67.17 Million | -18.89% |
| 2020-12-31 | $82.81 Million | +84.96% |
| 2019-12-31 | $44.77 Million | -6.22% |
| 2018-12-31 | $47.74 Million | -- |
About Elutia Inc.
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women's Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators;… Read more